Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clint Pecenka

Showing results (21-30 of 98) with videos related to

Pageof 10
Sort By:
Vaccine|November 14, 2018
Re-evaluating the cost and cost-effectiveness of rotavirus vaccination in Bangladesh, Ghana, and Malawi: A comparison of three rotavirus vaccinesClint Pecenka, Frederic Debellut, Naor Bar-Zeev, et al.
Journal of the Pediatric Infectious Diseases Society|December 21, 2020
Estimating the Economic Impact of Respiratory Syncytial Virus and Other Acute Respiratory Infections Among Infants Receiving Care at a Referral Hospital in MalawiRanju Baral, Ivan Mambule, Elisabeth Vodicka, et al.
Vaccine|November 7, 2017
Potential impact and cost-effectiveness of rotavirus vaccination in AfghanistanPalwasha Anwari, Frederic Debellut, Clint Pecenka, et al.
Journal of Global Health|December 12, 2025
Estimating the economic burden of respiratory syncytial virus infection among children <2 years old seeking care in North-West NigeriaFarina Leonie Shaaban, Maria Ahuoiza Garba, An Nguyen, et al.
Vaccine|September 10, 2023
Impact and cost-effectiveness of strategies to prevent respiratory syncytial virus (RSV) disease in Vietnam: A modelling studyLien Anh Ha Do, Nguyen Thanh Nhan Le, Sarwat Mahmud, et al.
Vaccines|February 26, 2022
Does Anybody Want an Injectable Rotavirus Vaccine, and Why? Understanding the Public Health Value Proposition of Next-Generation Rotavirus VaccinesWilliam P Hausdorff, Jessica Price, Frédéric Debellut, et al.
Plos One|June 23, 2018
Forecasting demand for maternal influenza immunization in low- and lower-middle-income countriesFrédéric Debellut, Nathaniel Hendrix, Justin R Ortiz, et al.
Vaccine|June 27, 2020
The impact of maternal RSV vaccine to protect infants in Gavi-supported countries: Estimates from two modelsRanju Baral, Xiao Li, Lander Willem, et al.
The Lancet. Global Health|April 23, 2021
Evaluating the potential economic and health impact of rotavirus vaccination in 63 middle-income countries not eligible for Gavi funding: a modelling studyFrédéric Debellut, Andrew Clark, Clint Pecenka, et al.
Vaccine|October 3, 2024
Corrigendum to "Evaluation of the potential impact and cost-effectiveness of respiratory syncytial virus (RSV) prevention strategies for infants in Argentina" [Vaccine. Volume 42, Issue 23, 3 October 2024, 126234]Gonzalo Guiñazú, Julia Dvorkin, Sarwat Mahmud, et al.
Pageof 10

Showing results (21-30 of 98) with videos related to

Sort By:
Pageof 10
Vaccine|November 14, 2018
Re-evaluating the cost and cost-effectiveness of rotavirus vaccination in Bangladesh, Ghana, and Malawi: A comparison of three rotavirus vaccinesClint Pecenka, Frederic Debellut, Naor Bar-Zeev, et al.
Journal of the Pediatric Infectious Diseases Society|December 21, 2020
Estimating the Economic Impact of Respiratory Syncytial Virus and Other Acute Respiratory Infections Among Infants Receiving Care at a Referral Hospital in MalawiRanju Baral, Ivan Mambule, Elisabeth Vodicka, et al.
Vaccine|November 7, 2017
Potential impact and cost-effectiveness of rotavirus vaccination in AfghanistanPalwasha Anwari, Frederic Debellut, Clint Pecenka, et al.
Journal of Global Health|December 12, 2025
Estimating the economic burden of respiratory syncytial virus infection among children <2 years old seeking care in North-West NigeriaFarina Leonie Shaaban, Maria Ahuoiza Garba, An Nguyen, et al.
Vaccine|September 10, 2023
Impact and cost-effectiveness of strategies to prevent respiratory syncytial virus (RSV) disease in Vietnam: A modelling studyLien Anh Ha Do, Nguyen Thanh Nhan Le, Sarwat Mahmud, et al.
Vaccines|February 26, 2022
Does Anybody Want an Injectable Rotavirus Vaccine, and Why? Understanding the Public Health Value Proposition of Next-Generation Rotavirus VaccinesWilliam P Hausdorff, Jessica Price, Frédéric Debellut, et al.
Plos One|June 23, 2018
Forecasting demand for maternal influenza immunization in low- and lower-middle-income countriesFrédéric Debellut, Nathaniel Hendrix, Justin R Ortiz, et al.
Vaccine|June 27, 2020
The impact of maternal RSV vaccine to protect infants in Gavi-supported countries: Estimates from two modelsRanju Baral, Xiao Li, Lander Willem, et al.
The Lancet. Global Health|April 23, 2021
Evaluating the potential economic and health impact of rotavirus vaccination in 63 middle-income countries not eligible for Gavi funding: a modelling studyFrédéric Debellut, Andrew Clark, Clint Pecenka, et al.
Vaccine|October 3, 2024
Corrigendum to "Evaluation of the potential impact and cost-effectiveness of respiratory syncytial virus (RSV) prevention strategies for infants in Argentina" [Vaccine. Volume 42, Issue 23, 3 October 2024, 126234]Gonzalo Guiñazú, Julia Dvorkin, Sarwat Mahmud, et al.
Pageof 10